Skip to main content
S. 4302 117th Congress Senate

Biologics Market Transparency Act of 2022

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.

Introduced: May 25, 2022 Introduced by: Tim Kaine Democratic · Virginia See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 25, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
May 25, 2022
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 25, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)

 Plain-English summary Congressional Research Service

Biologics Market Transparency Act of 2022

This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.

 Related & companion bills 3
  • S 4348 FDASLA Act of 2022
  • HR 7035 Biologics Market Transparency Act of 2022
  • HR 7667 Food and Drug Amendments of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 1 Republican 2
R
Cassidy, Bill
Louisiana · May 25, 2022
 D
Hassan, Margaret Wood
New Hampshire · May 25, 2022
 R
Marshall, Roger
Kansas · May 25, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). S. 4302: Biologics Market Transparency Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-S-4302/
MLA
"S. 4302: Biologics Market Transparency Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-4302/.
Bluebook (legal)
S. 4302, 117th Cong. (2026), https://openamerica.io/bill/117-S-4302/.
Markdown link
[S. 4302: Biologics Market Transparency Act of 2022](https://openamerica.io/bill/117-S-4302/)
Report a problem